SCHEMBL30079474

SCHEMBL30079474

COc1nccc(Cl)c1N1CCC(N)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.42
HTR3E A5X5Y0 1/20 0.39
MEN1 O00255 1/20 0.39
HTR3B O95264 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
HTR3A P46098 1/20 0.39
KMT2A Q03164 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
AKT2 P31751 1/20 0.38
SUV39H2 Q9H5I1 5/20 0.38
SSTR2 P30874 6/20 0.38
PTPN11 Q06124 3/20 0.37
KDM1A O60341 1/20 0.37
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079301 0.84 HRH3 (0.43) HRH3AKT2SSTR2CHRNB4CHRNA3
SCHEMBL30079412 0.80 HRH3 (0.40) HRH3AKT2SSTR2KDM1ACHRNB4
SCHEMBL30079400 0.80 C5AR1 (0.44) HRH3AKT2SSTR2KDM1A
SCHEMBL30079321 0.78 SUV39H2 (0.35) KMT2ASUV39H2
SCHEMBL30079314 0.77 ALDH1A1 (0.41) MEN1TSHRKMT2A
SCHEMBL4509928 0.72 HTR3E (0.54) HRH3HTR3EMEN1HTR3BCYP1A2
SCHEMBL16684915 0.68 SMARCA2 (0.47) HRH3SUV39H2SSTR2
Hydrochloric Acid SCHEMBL16684752 0.67 SMARCA2 (0.46) HRH3SUV39H2SSTR2
SCHEMBL4490992 0.67 HTR3E (0.43) HRH3HTR3EMEN1HTR3BCYP1A2
Hydrochloric Acid SCHEMBL2275791 0.67 SMARCA2 (0.46) HRH3SUV39H2SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed